251 related articles for article (PubMed ID: 34909742)
1. Evidence-Based Consensus Recommendations for the Evolving Treatment of Patients with High-Risk and Advanced Cutaneous Squamous Cell Carcinoma.
Rabinowits G; Migden MR; Schlesinger TE; Ferris RL; Freeman M; Guild V; Koyfman S; Pavlick AC; Swanson N; Wolf GT; Dinehart SM
JID Innov; 2021 Dec; 1(4):100045. PubMed ID: 34909742
[TBL] [Abstract][Full Text] [Related]
2. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
[TBL] [Abstract][Full Text] [Related]
3. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; van Akkooi A; Bataille V; Bastholt L; Dreno B; Dummer R; Fargnoli MC; Forsea AM; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Lallas A; Leiter U; Malvehy J; Del Marmol V; Moreno-Ramirez D; Pellacani G; Peris K; Saiag P; Tagliaferri L; Trakatelli M; Ioannides D; Vieira R; Zalaudek I; Arenberger P; Eggermont AMM; Röcken M; Grob JJ; Lorigan P;
Eur J Cancer; 2023 Nov; 193():113252. PubMed ID: 37708630
[TBL] [Abstract][Full Text] [Related]
4. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
[TBL] [Abstract][Full Text] [Related]
5. American Head and Neck Society position statement on the use of PD-1 inhibitors for treatment of advanced cutaneous squamous cell carcinoma.
Schmalbach CE; Ow TJ; Choi KY; O'Leary M; Lin A; Hughley BB; Emerick KS; Moore B; Lee NY; Zandberg DP; Wang SJ
Head Neck; 2023 Jan; 45(1):32-41. PubMed ID: 36181317
[TBL] [Abstract][Full Text] [Related]
6. Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report.
Ashraf S; Alsharedi M
Stem Cell Investig; 2021; 8():19. PubMed ID: 34631872
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
[TBL] [Abstract][Full Text] [Related]
8. Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinion.
Argenziano G; Fargnoli MC; Fantini F; Gattoni M; Gualdi G; Pastore F; Pellacani G; Quaglino P; Queirolo P; Troiani T
Ther Adv Med Oncol; 2022; 14():17588359211066272. PubMed ID: 35035534
[TBL] [Abstract][Full Text] [Related]
9. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; van Akkooi A; Bataille V; Bastholt L; Dreno B; Dummer R; Fargnoli MC; Forsea AM; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Lallas A; Leiter U; Malvehy J; Del Marmol V; Moreno-Ramirez D; Pellacani G; Peris K; Saiag P; Tagliaferri L; Trakatelli M; Ioannides D; Vieira R; Zalaudek I; Arenberger P; Eggermont AMM; Röcken M; Grob JJ; Lorigan P;
Eur J Cancer; 2023 Nov; 193():113251. PubMed ID: 37717283
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
Que SKT; Zwald FO; Schmults CD
J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy and Hypofractionated Radiotherapy in Older Patients with Locally Advanced Cutaneous Squamous-Cell Carcinoma of the Head and Neck: A Proposed Paradigm by the International Geriatric Radiotherapy Group.
Nguyen NP; Thariat J; Gorobets O; Vinh-Hung V; Kim L; Blanco SC; Vasileiou M; Arenas M; Mazibuko T; Giap H; Vincent F; Chi A; Loganadane G; Mohammadianpanah M; Rembielak A; Karlsson U; Ali A; Bose S; Page BR
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894347
[TBL] [Abstract][Full Text] [Related]
12. Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: The Current and Future Role of Radiation Therapy in the Era of Immunotherapy.
Ferini G; Palmisciano P; Forte S; Viola A; Martorana E; Parisi S; Valenti V; Fichera C; Umana GE; Pergolizzi S
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454779
[TBL] [Abstract][Full Text] [Related]
13. Clinician perspectives on the factors influencing prognostic stratification by the American Joint Commission on Cancer Head and Neck Cutaneous Squamous Cell Carcinoma Staging.
Watts F; Palme CE; Porceddu S; Sundaresan P; Clark JR; Gupta R
Surgery; 2021 Nov; 170(5):1467-1473. PubMed ID: 34130810
[TBL] [Abstract][Full Text] [Related]
14. Update on Management Recommendations for Advanced Cutaneous Squamous Cell Carcinoma.
García-Foncillas J; Tejera-Vaquerizo A; Sanmartín O; Rojo F; Mestre J; Martín S; Azinovic I; Mesía R
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158897
[TBL] [Abstract][Full Text] [Related]
15. Management of Cutaneous Squamous Cell Carcinoma of the Scalp: The Role of Imaging and Therapeutic Approaches.
Verdaguer-Faja J; Toll A; Boada A; Guerra-Amor Á; Ferrándiz-Pulido C; Jaka A
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339415
[TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced cutaneous squamous cell carcinoma: a Mohs surgery and dermatologic oncology perspective.
Wilmas KM; Nguyen QB; Patel J; Silapunt S; Migden MR
Future Oncol; 2021 Dec; 17(35):4971-4982. PubMed ID: 34608809
[TBL] [Abstract][Full Text] [Related]
17. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
[TBL] [Abstract][Full Text] [Related]
18. Management of Locally Advanced Cutaneous Squamous Cell Carcinoma of the Scalp: A Case Report and Literature Review.
Nuttall E; Hudnall RM; Richa T
Cureus; 2023 Feb; 15(2):e34938. PubMed ID: 36938196
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of advanced cutaneous squamous cell carcinoma.
Dessinioti C; Pitoulias M; Stratigos AJ
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):39-50. PubMed ID: 34592000
[TBL] [Abstract][Full Text] [Related]
20. CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma.
Migden MR; Chandra S; Rabinowits G; Chen CI; Desai J; Seluzhytsky A; Sasane M; Campanelli B; Chen Z; Freeman ML; Ibrahim SF; Khushalani NI; Andria M; Ruiz E
Future Oncol; 2020 Feb; 16(4):11-19. PubMed ID: 31951149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
